Streetbeat News

Stock Prices

HTLF

Heartland Financial USA (NASDAQ:HTLF) received three somewhat bullish and one indifferent rating from analysts in the last quarter, with no bearish ratings. The average price target is $35.5, representing an upside from the current price of $30.24, but this target is a 0.7% decrease from the previous target of $35.75. Analysts' ratings are a tool for investors to gauge market sentiment and are updated quarterly based on various research methods.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 3:00 pm

NNOX

Over the past quarter, Nano X Imaging (NASDAQ:NNOX) received 4 analyst ratings, with 1 bullish and 3 somewhat bullish. No indifferent, somewhat bearish, or bearish ratings were given. The average 12-month price target for NNOX is $24.62, with a high of $30.00 and a low of $14.50. This average price target represents a 17.93% decrease from the previous target of $30.00. Analysts use various methods to determine their ratings, including financial statements and insider information, but their predictions are not infallible.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 3:00 pm

AVAXUSD

Avalanche (CRYPTO: AVAX) has seen a 3.29% increase in price over the last 24 hours, reaching $20.97, and a 5.0% gain over the past week. Despite the recent uptick, it is still far from its all-time high of $144.96. The trading volume has decreased by 50.0% over the past week, while the circulating supply has increased by 1.9% to 365.11 million, approximately 50.71% of the max supply. AVAX's market cap is currently ranked #14 at $7.64 billion.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 3:00 pm

PINS

Piper Sandler analyst Thomas Champion has maintained an Overweight rating on Pinterest (NYSE:PINS) and increased the price target from $37 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:54 pm

NET

Investor Business Daily's SwingTrader has reportedly purchased shares of Cloudflare, which could indicate a positive sentiment towards the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:52 pm

KSCP

Knightscope has started selling an Automated Gunshot Detection system, which could enhance its product offering and potentially increase its market share in the security technology sector.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:50 pm

BZAMF

BZAM Ltd. reported a 112% YoY increase in Q3 net revenue to CA$21 million, driven by a merger with The Green Organic Dutchman Holdings Ltd. Despite revenue growth, the company experienced a net loss from operations of CA$17 million, up from CA$6.8 million last year. BZAM implemented cost reduction measures, including layoffs and facility consolidations. Shares of BZAMF fell 0.9664% to $0.1178 post-announcement.

Portfolio Pulse from Jelena Martinovic

November 29, 2023 | 2:49 pm

CRWD

Piper Sandler analyst Rob Owens has maintained an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $210 to $245.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 2:49 pm

CRM

Salesforce, Inc. (CRM) is expected to release its Q3 earnings after market close on Nov. 29, 2023, with anticipated earnings of $2.06 per share and revenue of $8.73 billion. The company previously reported better-than-expected Q2 results and provided strong FY24 guidance. CRM shares slightly increased by 0.1% to $224.92 recently. Analysts have made various adjustments to CRM's price targets, with Citigroup raising it to $247, Keybanc reducing it to $268, BMO Capital lowering it to $252, Piper Sandler cutting it to $232, and Truist Securities maintaining it at $275.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 2:49 pm

BIVI

COCH

CPHI

FTCH

TGL

VVOS

U.S. stocks traded higher with the Nasdaq Composite gaining over 100 points. The U.S. economy grew by an annualized 5.2% in Q3, surpassing estimates. Vivos Therapeutics (VVOS) surged after FDA clearance for a sleep apnea device. China Pharma (CPHI) rose after completing testing for a dry eye device. Envoy Medical (COCH) gained following a Q3 profit report. BioVie (BIVI) dropped after Phase 3 trial data for an Alzheimer's drug. Treasure Global (TGL) fell post-pricing of a public offering. Farfetch (FTCH) declined after postponing its Q3 financial results announcement.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 2:48 pm